In brief
On 10 June 2024, the Member State Coordination Group on Health Technology Assessment adopted two new HTA guidance on outcomes of joint clinical assessments and reporting requirements.
Key takeaways
In particular, the guidance on outcomes for clinical assessments aims at supporting both Member States authorities in defining the scope of such assessments and those responsible for such assessments in reporting all the elements needed by Member States to properly conduct clinical value-added analysis of health technologies at the national level.
The guidance on reporting requirements identify how assessors should deal with multiplicity issues and complementary analyses in the reporting of joint clinical assessments.
These guidance are an essential tool for health technology developers since they allow the correct identification of the relevant elements within evaluation proposals.
